Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer
出版年份 2013 全文链接
标题
Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer
作者
关键词
Intraperitoneal chemotherapy, Hyaluronic acid, Hydrogel, Cisplatin, Peritoneal dissemination
出版物
SURGERY TODAY
Volume 44, Issue 5, Pages 919-926
出版商
Springer Nature
发表日期
2013-07-25
DOI
10.1007/s00595-013-0674-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry
- (2011) Yoh Isobe et al. Gastric Cancer
- Drug release behaviors of a pH sensitive semi-interpenetrating polymer network hydrogel composed of poly(vinyl alcohol) and star poly[2-(dimethylamino)ethyl methacrylate]
- (2011) Wei Wu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors
- (2011) Gaurav Bajaj et al. JOURNAL OF CONTROLLED RELEASE
- 5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice
- (2010) Yongsheng Wang et al. BMC CANCER
- Hyaluronic acid–paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts
- (2010) Ilaria De Stefano et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Spatial distribution of intraperitoneally administrated paclitaxel nanoparticles solubilized with poly (2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) in peritoneal metastatic nodules
- (2010) Takao Kamei et al. CANCER SCIENCE
- The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model
- (2010) Jieun Yu et al. INVESTIGATIONAL NEW DRUGS
- pH effect on the synthesis, shear properties, and homogeneity of iron-crosslinked hyaluronic acid-based gel/adhesion barrier
- (2010) Irada Isayeva et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
- Drug Delivery Systems for Intraperitoneal Therapy
- (2010) Gaurav Bajaj et al. PHARMACEUTICAL RESEARCH
- Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis
- (2009) H. Ishigami et al. ANNALS OF ONCOLOGY
- Suppression of in vivo tumor growth by using a biodegradable thermosensitive hydrogel polymer containing chemotherapeutic agent
- (2009) Mi Kyung Kwak et al. INVESTIGATIONAL NEW DRUGS
- Pharmacokinetics and Disposition of a Localized Lymphatic Polymeric Hyaluronan Conjugate of Cisplatin in Rodents
- (2009) Shuang Cai et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Recent results of therapy for scirrhous gastric cancer
- (2009) Masahide Ikeguchi et al. SURGERY TODAY
- Intra-peritoneal administration of paclitaxel with non-animal stabilized hyaluronic acid as a vehicle – A new strategy against peritoneal dissemination of gastric cancer
- (2008) Jun Yamada et al. CANCER LETTERS
- Pharmacologic principles of intraperitoneal chemotherapy for the treatment of ovarian cancer
- (2008) S.B. HOWELL INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery
- (2008) Chaoliang He et al. JOURNAL OF CONTROLLED RELEASE
- Intralymphatic Chemotherapy Using a Hyaluronan–Cisplatin Conjugate
- (2008) Shuang Cai et al. JOURNAL OF SURGICAL RESEARCH
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
- Cisplatin‐incorporated hyaluronic acid nanoparticles based on ion‐complex formation
- (2007) Young‐Il Jeong et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started